Concourse Financial Group Securities, Inc. Medicinova Inc Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding MNOV
# of Institutions
22Shares Held
5.08MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.43 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$896,4760.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA687KShares$885,6840.0% of portfolio
-
Citigroup Inc592KShares$763,6240.0% of portfolio
-
Geode Capital Management, LLC Boston, MA526KShares$678,4000.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $63.3M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...